# Zhida Pharma

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zhida-pharma

- Industry: Pharmaceuticals
- Headquarters: Shaoxing, China
- Latest round: Series A (Sep 1, 2022)
- Investors on record: 1

## About

Founded in 2018 and based in Shaoxing, China, Zhida Pharma is a pharmaceutical company that focuses on the research and development of nano-drug delivery platform technology. In 2022, the company raised series A funding from new investor Sinopharm-CICC Capital. In August 2024, the firm closed a strategic investment.

The company's core technologies include nanoliposome drug delivery platform, albumin nanoparticle drug delivery platform, peptide nano drug delivery platform and high-efficiency in vivo nucleic acid drug delivery platform. It also has a GMP-validated nanoliposome drug production line.


The company’s revenue is generated by providing nano drug delivery platform.

## Funding rounds

- Series A, Sep 1, 2022 — Sinopharm-CICC Capital

## Investors

- Sinopharm-CICC Capital (https://capitalatlas.ai/funds/sinopharm-cicc-capital) — Series A